Accepted Manuscript (unedited) The manuscript will undergo copyediting, typesetting, and review of the resulting proof before it is published in its final form. 1 | Page Review The Art of Bioimmunogenomics (BIGs) 5.0 in CAR-T Cell Therapy for Lymphoma Management Dito Anurogo 1,2 , Dewi Luthfiana 3 , Nuralfin Anripa 4,5 , Apriliani Ismi Fauziah 6 , Maratu Soleha 7,8 , Laila Rahmah 9,10 , Hana Ratnawati 11 , Teresa Liliana Wargasetia 12 , Sari Eka Pratiwi 13 , Riswal Nafi Siregar 14 , Ratis Nour Sholichah 15 , Muhammad Sobri Maulana 16 , Taruna Ikrar 17, 18,19 , Yu Hsiang Chang 1,20 , Jiantai Timothy Qiu 1,21,22** 1 International PhD Program in Cell Therapy and Regenerative Medicine (IPCTRM), College of Medicine, Taipei Medical University (TMU), Taiwan, email: d151109004@tmu.edu.tw 2 Faculty of Medicine and Health Sciences, Universitas Muhammadiyah Makassar, Indonesia, email: dito.anurogo@med.unismuh.ac.id 3 Bioinformatics Research Center, Indonesian Institute of Bioinformatics (INBIO), Malang, Indonesia, email: dewiluthfiana7@gmail.com 4 Department of Environmental Science, Universitas Dumoga Kotamobagu, Indonesia. 5 Faculty of Medicine Ramathibodi Hospital, Mahidol University, Thailand, email: nuralfin.anripa@gmail.com 6 MSc Program in Tropical Medicine, Kaohsiung Medical University, Taiwan, email: aprilianiismifauziah@gmail.com 7 National Research and Innovation Agency, Indonesia 8 Sekolah Tinggi Ilmu Kesehatan IKIFA, Indonesia, email: maratu15@yahoo.com 9 School of Medicine Tehran University of Medical Sciences, Tehran, Iran 10 Universal Scientific Education and Research Network (USERN)), email: lailarahmah8@gmail.com, akungameku2110@gmail.com 11 Faculty of Medicine, Maranatha Christian University, Indonesia, email: hana.ratnawati@maranatha.ac.id 12 Faculty of Medicine, Maranatha Christian University, Indonesia, email: Teresa.lw@med.maranatha.edu 13 Department of Biology and Pathobiology, Faculty of Medicine, Tanjungpura University, Indonesia, email: sariekapratiwi@medical.untan.ac.id 14 National Research and Innovation Agency, Indonesia, email: risw001@brin.go.id 15 Departement of Biotechnology, Postgraduate School of Universitas Gadjah Mada, Indonesia, email: ratisnoursholichah@mail.ugm.ac.id 16 Community Health Center (Puskesmas) Temon 1, Kulon Progo, Daerah Istimewa Yogyakarta, email: muhammadsobrimaulana31@gmail.com 17 Chairman of Medical Council, The Indonesian Medical Council, Jakarta, Indonesia 18 Aivita Biomedical Inc., Irvine, California, USA 19 Department of Pharmacology, Faculty of Medicine, Malahayati University, Bandar Lampung, Indonesia, email: dr.ikrar.phd@gmail.com 20 Locus Cell Co., LTD., New Taipei City, Taiwan, ROC., email: dtped070@yahoo.com.tw 21 Taipei Medical University Hospital, Taipei, Taiwan, ROC, email: 191010@h.tmu.edu.tw 22 Department of Obstetrics and Gynecology, Taipei Medical University Hospital, Taipei, Taiwan, ROC., email: jtqiu1010@tmu.edu.tw * Correspondence: Prof. Jiantai Timothy Qiu, M.D., Ph.D. Email: 191010@h.tmu.edu.tw Running Titles: Bioimmunogenomics (BIGs) 5.0: CAR-T Cells for Lymphoma Management How to cite this article: Anurogo D, Luthfiana D, Anripa N, Fauziah AI, Soleha M, Rahmah L, Ratnawati H, Wargasetia TL, Pratiwi SE, Siregar RN, Sholichah RN, Maulana MS, Ikrar T, Chang YH, Qiu JT. The Art of Bioimmunogenomics (BIGs) 5.0 in CAR-T Cell Therapy for Lymphoma Management. Advanced Pharmaceutical Bulletin, Doi: 10.34172/apb.2024.034 Accepted Manuscript